Lv1
48 积分 2024-11-07 加入
An Ionic Liquid-Based Enteric Formulation for Enhanced Oral Delivery of Semaglutide in Type 2 Diabetes Mellitus
1个月前
已完结
Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
1个月前
已完结
Engineering Supramolecular Nanofiber Depots from a Glucagon-Like Peptide-1 Therapeutic
1个月前
已完结
Biodegradable Hollow Nanoscavengers Restore Liver Functions to Reverse Insulin Resistance in Type 2 Diabetes
1个月前
已完结
MicroRNAs Dependent G‐ELNs Based Intervention Improves Glucose and Fatty Acid Metabolism While Protecting Pancreatic β‐Cells in Type 2 Diabetic Mice
1个月前
已完结
The weight-loss-independent hepatoprotective benefits of semaglutide are orchestrated by intrahepatic sinusoidal endothelial GLP-1 receptors
2个月前
已完结
Idf Diabetes Atlas: Global, Regional and National Diabetes Prevalence Estimates for 2024 and Projections for 2050
2个月前
已完结
Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist
2个月前
已完结
Molecular dynamics insights into the binding interactions of semaglutide with human serum albumin
2个月前
已完结
Glucose-Responsive Polyzwitterionic Nanoparticles with Enhanced and Targeted Intestinal Epithelial Absorption for Oral Insulin Delivery
3个月前
已完结
皖公网安备34019202002308
